195 related articles for article (PubMed ID: 7515025)
21. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
[TBL] [Abstract][Full Text] [Related]
22. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
23. [Expression of CD44 alternative splicing variants in lung cancer].
Ohgami A; Sugio K; Mitsudomi T; Tsuda T; Yasumoto K
Nihon Rinsho; 1995 Jul; 53(7):1704-9. PubMed ID: 7630011
[TBL] [Abstract][Full Text] [Related]
24. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.
Hudson DL; Speight PM; Watt FM
Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 in human lung tumors.
Penno MB; August JT; Baylin SB; Mabry M; Linnoila RI; Lee VS; Croteau D; Yang XL; Rosada C
Cancer Res; 1994 Mar; 54(5):1381-7. PubMed ID: 7509720
[TBL] [Abstract][Full Text] [Related]
27. A PCR-based method for the analysis of human CD44 splice products.
van Weering DH; Baas PD; Bos JL
PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
[TBL] [Abstract][Full Text] [Related]
28. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
29. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
[TBL] [Abstract][Full Text] [Related]
30. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants.
Bartolazzi A; Jackson D; Bennett K; Aruffo A; Dickinson R; Shields J; Whittle N; Stamenkovic I
J Cell Sci; 1995 Apr; 108 ( Pt 4)():1723-33. PubMed ID: 7542258
[TBL] [Abstract][Full Text] [Related]
31. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
[TBL] [Abstract][Full Text] [Related]
33. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.
Screaton GR; Bell MV; Bell JI; Jackson DG
J Biol Chem; 1993 Jun; 268(17):12235-8. PubMed ID: 8509359
[TBL] [Abstract][Full Text] [Related]
34. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
35. Expression of two isoforms of CD44 in human endometrium.
Behzad F; Seif MW; Campbell S; Aplin JD
Biol Reprod; 1994 Oct; 51(4):739-47. PubMed ID: 7529574
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
37. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines.
Southgate J; Trejdosiewicz LK; Smith B; Selby PJ
Int J Cancer; 1995 Aug; 62(4):449-56. PubMed ID: 7543458
[TBL] [Abstract][Full Text] [Related]
38. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
[TBL] [Abstract][Full Text] [Related]
39. Expression and function of the CD44 glycoprotein in melanoma cell lines.
East JA; Mitchell SD; Hart IR
Melanoma Res; 1993 Oct; 3(5):341-6. PubMed ID: 7507366
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
Parker D
Lancet; 1995 Mar; 345(8949):583-4. PubMed ID: 7539877
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
